Country: Cyprus
Language: Greek
Source: Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας
ROPINIROLE HYDROCHLORIDE
DELORBIS PHARMACEUTICALS LTD
N04BC04
ROPINIROLE HYDROCHLORIDE
3MG
FILM COATED TABLETS
8000002043 - ROPINIROLE HYDROCHLORIDE - 3.42 MG
ORAL USE
Με Ιατρική Συνταγή που Επαναλαμβάνεται
ROPINIROLE
01 - PACK WITH 7 TABS IN BLISTER(S) PVC/ACLAR/ALU - 7 - TABLET - 310014601 - Εγκεκριμένο; - 02 - PACK WITH 12 TABS IN BLISTER(S) PVC/ACLAR/ALU - 12 - TABLET - 310014602 - Εγκεκριμένο; - 03 - PACK WITH 21 TABS IN BLISTER(S) PVC/ACLAR/ALU - 21 - TABLET - 310014603 - Εγκεκριμένο; - 04 - PACK WITH 28 TABS IN BLISTER(S) PVC/ACLAR/ALU - 28 - TABLET - 310014604 - Εγκεκριμένο; - 05 - PACK WITH 30 TABS IN BLISTER(S) - 30 - TABLET - 310014605 - Εγκεκριμένο; - 06 - PACK WITH 42 TABS IN BLISTER(S) PVC/ACLAR/ALU - 42 - TABLET - 310014606 - Εγκεκριμένο; - 07 - PACK WITH 50 TABS IN BLISTER(S) - 50 - TABLET - 310014607 - Εγκεκριμένο; - 08 - PACK WITH 60 TABS IN BLISTER(S) - 60 - TABLET - 310014608 - Εγκεκριμένο; - 09 - PACK WITH 84 TABS IN BLISTER(S) PVC/ACLAR/ALU - 84 - TABLET - 310014609 - Εγκεκριμένο; - 10 - PACK WITH 90 TABS IN BLISTER(S) - 90 - TABLET - 310014610 - Εγκεκριμένο; - 11 - PACK WITH 126 TABS IN BLISTER(S) - 126 - TABLET - 310014611 - Εγκεκριμένο; - 12 - PACK WITH 210 TABS IN BLISTER(S) - 210 - TABLET - 310014612 - Εγκεκριμένο; - 13 - PACK WITH 7 TABS IN BLISTER(S) ALU/ALU - 7 - TABLET - 310014613 - Εγκεκριμένο; - 14 - PACK WITH 12 TABS IN BLISTER(S) ALU/ALU - 12 - TABLET - 310014614 - Εγκεκριμένο; - 15 - PACK WITH 21 TABS IN BLISTER(S) ALU/ALU - 21 - TABLET - 310014615 - Εγκεκριμένο; - 16 - PACK WITH 28 TABS IN BLISTER(S) ALU/ALU - 28 - TABLET - 310014616 - Εγκεκριμένο; - 17 - PACK WITH 42 TABS IN BLISTER(S) ALU/ALU - 42 - TABLET - 310014617 - Εγκεκριμένο; - 18 - PACK WITH 84 TABS IN BLISTER(S) ALU/ALU - 84 - TABLET - 310014618 - Εγκεκριμένο; - 21 - BOTTLE WITH 21 TABS - 21 - TABLET - 310014621 - Εγκεκριμένο; - 22 - BOTTLE WITH 28 TABS - 28 - TABLET - 310014622 - Εγκεκριμένο; - 23 - BOTTLE WITH 30 TABS - 30 - TABLET - 310014623 - Εγκεκριμένο; - 24 - BOTTLE WITH 42 TABS - 42 - TABLET - 310014624 - Εγκεκριμένο; - 25 - BOTTLE WITH 50 TABS - 50 - TABLET - 310014625 - Εγκεκριμένο; - 26 - BOTTLE WITH 60 TABS - 60 - TABLET - 310014626 - Εγκεκριμένο; - 27 - BOTTLE WITH 84 TABS - 84 - TABLET - 310014627 - Εγκεκριμένο; - 28 - BOTTLE WITH 90 TABS - 90 - TABLET - 310014628 - Εγκεκριμένο; - 29 - BOTTLE WITH 126 TABS - 126 - TABLET - 310014629 - Εγκεκριμένο; - 30 - BOTTLE WITH 210 TABS - 210 - TABLET - 310014630 - Εγκεκριμένο
PACKAGE LEAFLET: INFORMATION FOR THE USER ROTEQ 0.25 MG FILM-COATED TABLETS ROTEQ 0.5 MG FILM-COATED TABLETS ROTEQ 1 MG FILM-COATED TABLETS ROTEQ 2 MG FILM-COATED TABLETS ROTEQ 3 MG FILM-COATED TABLETS ROTEQ_ _4 MG FILM-COATED TABLETS Ropinirole READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Roteq is and what it is used for 2. What you need to know before you take Roteq 3. How to take Roteq 4. Possible side effects 5. How to store Roteq 6. Contents of the pack and other information 1. WHAT ROTEQ IS AND WHAT IT IS USED FOR The active ingredient of Roteq is ropinirole, which belongs to a group of medicines called DOPAMINE AGONISTS. Dopamine agonists affect the brain in a similar way to a natural substance called dopamine. ROTEQ IS USED TO TREAT PARKINSON’S DISEASE People with Parkinson’s disease have low levels of dopamine in some parts of their brains. Ropinirole has effects similar to those of natural dopamine, so it helps to reduce the symptoms of Parkinson’s disease. TO TREAT THE SYMPTOMS OF MODERATE-TO-SEVERE RESTLESS LEGS SYNDROME Restless Legs Syndrome (RLS) is also called Ekbom syndrome. People with Restless Legs Syndrome have an irresistible urge to move their legs, and sometimes their arms and other parts of their bodies. Usually, they have unpleasant sensations in their limbs – sometimes described as ‘crawling’ or ‘bubbling’ – which can begin as soon as they sit or lie down, and are relieved only by movement. So they often have problems with sittin Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Roteq 0,25 mg Film-coated tablets Roteq 0,5 mg Film-coated tablets Roteq 1 mg Film-coated tablets Roteq 2 mg Film-coated tablets Roteq 3 mg Film-coated tablets Roteq 4 mg Film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Roteq 0,25 mg film-coated tablets: One film-coated tablet contains Ropinirole hydrochloride, equivalent to 0,25 mg of Ropinirole. Excipient(s) with known effect: each film-coated tablet contains 107.215 mg lactose monohydrate. Roteq 0.5 mg film-coated tablets: One film-coated tablet contains Ropinirole hydrochloride, equivalent to 0,5 mg of Ropinirole. Excipient(s) with known effect: each film-coated tablet contains 106.93 mg lactose monohydrate. Roteq 1 mg film-coated tablets: One film-coated tablet contains Ropinirole hydrochloride, equivalent to 1 mg of Ropinirole. Excipient(s) with known effect: each film-coated tablet contains 106.36 mg lactose monohydrate. Roteq 2 mg film-coated tablets: One film-coated tablet contains Ropinirole hydrochloride, equivalent to 2 mg of Ropinirole. Excipient(s) with known effect: each film-coated tablet contains 105.22 mg lactose monohydrate. Roteq 3 mg film-coated tablets: One film-coated tablet contains Ropinirole hydrochloride, equivalent to 3 mg of Ropinirole. Excipient(s) with known effect: each film-coated tablet contains 104.08 mg lactose monohydrate. Roteq 4 mg film-coated tablets: One film-coated tablet contains Ropinirole hydrochloride, equivalent to 4 mg of Ropinirole. Excipient(s) with known effect: each film-coated tablet contains 102.94 mg lactose monohydrate. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet. Roteq 0,25 mg film-coated tablets: White to off white coloured, round, biconvex film-coated tablets, plain on both sides. Roteq 0,5 mg film-coated tablets: Pale yellow coloured, round, biconvex film-coated tablets, plain on both sides. 1 Roteq 1 mg film-coated tablets: Greenish yellow coloured, round, biconvex film-coat Read the complete document